Halozyme Therapeutics, Inc. (HALO)
72.96
+1.29
(+1.80%)
USD |
NASDAQ |
Jan 14, 16:00
72.96
0.00 (0.00%)
After-Hours: 20:00
Halozyme Therapeutics Price: 72.96 for Jan. 14, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Johnson & Johnson | 218.55 |
| Merck & Co., Inc. | 111.01 |
| AIM ImmunoTech, Inc. | 1.31 |
| Stryker Corp. | 359.39 |
| Skye Bioscience, Inc. | 1.02 |
Price Related Metrics
| PE Ratio | 15.34 |
| PS Ratio | 7.369 |
| PEG Ratio | 0.2671 |
| Price to Book Value | 17.03 |
| Price to Free Cash Flow | 15.20 |
| Earnings Yield | 6.52% |
| Market Cap | 8.580B |
| PEGY Ratio | 0.2671 |
| Operating PE Ratio | 12.42 |
| Normalized PE Ratio | 15.34 |